The present study was conducted to determine how long hyperplastic polyps (HPs) and fundic gland hyperplastic polyps (FGPs) should be endoscopically followed up. Our findings showed that in the case of FGPs, yearly endoscopy is not required and it is sufficient to repeat X-ray and compare films with those obtained in the previous year. In contrast, yearly follow-up by endoscopy is necessary in the case of HPs.
INTRODUCTION
Gastric polyps (benign epithelial elevated lesions in the stomach) are one of the diseases gastroenterologists most often encounter in daily clinical practice.
They are also often discovered by X-ray in mass examination.
Discovery of gastric polyps in X-rays conducted to detect stomach cancer is followed by endoscopy for more detailed examinations. Even if polyps are found benign as a result of detailed examinations, it is recommended at present that patients receive follow-up examinations one year later. If lesions are found in X-rays the next year, detailed examinations by endoscopy is repeated, resulting in endoscopic procedures every year.
In order to determine if yearly endoscopic monitoring is necessary, we studied the fate of foveolar type hyperplastic polyps (HPs) and fundic gland hyperplastic polyps (FGPs), which account for a great majority of gastric polyps.
SUBJECTS
Included in the present study were the following patients who, undergoing endoscopy in Tokyo Medical University Hospital in 1994, were histologically diagnosed as having HPs or FGPs, and who were subsequently monitored for at least one year: (1) 95 (Table III) .
Degree of Inflammation
The degree of inflammation was determined by examining biopsy specimens taken from polyps. Among the 95 HP patients, inflammation was absent in no patient, mild in 3, moderate in 32, and severe in 9 of 60 with a mean score of 2.6, while among the 84 FGP patients, it was absent in 0, mild in 67, moderate in 17, and severe in 0 with a mean score of 1.2. Differences between the two groups were significant (p 0.001, U-test) (Table IV) .
Findings outlined in Sections 3.4 and 3.5 showed that the H. pylori infection rate is higher and inflammatory cell infiltration more marked in HP patients than in FGP patients. [2] . In contrast, however, HPs are reported to be cancerated in some patients [3] [4] [5] . Therefore, applying the same monitoring policy to HPs and FGPs may be cost-ineffective. In order to give an answer to this question, we evaluated morphological changes in HPs and FGPs and reviewed biopsy findings in patients with these lesions.
As reported by many authors [4, 6] , morphological changes were seen with both HPs and FGPs, but incidence was slightly higher with HPs.
Dysplastic or cancerous foci are often detected in excised HPs. In the present study, dysplastic foci were found in 30.8% of HP lesions, a very high rate probably partly due to the small number of lesions examined. In our previous study, dysplastic and cancerous foci were detected in 5% and 2.5%, respectively, of endoscopically excised HPs. In a similar study, Iijima [3] 4 The foveolar epithelium shows hyperplasia. Marked infiltration of lymphocytes, plasmacytes, and neutrophils is seen in the interstitium. Proliferation of capillaries is also observed. It showed a typical histological finding of HP (HE 200).
FIGURE 5 Mucus is found in the surface layer of this HP. H. pylori is found in the mucus and adhered to the surperficial epithelium (Giemsa x400). HPs, while the gastric mucosa is almost normal or free from atrophic changes in the presence of FGPs [12] . This difference is also thought to be due to lower incidence of H. pylori infections and milder inflammation in the presence of FGPs.
All these findings suggest that yearly endoscopic monitoring is unnecessary in FGP patients, but our data is not sufficient to establish the appropriate monitoring interval for these patients. In addition, during the monitoring of one FGP patient in the past, we observed the disappearance of an FGP which was followed by the onset of an IIa-type early stomach cancer at another site [13] . A similar event was also reported in some patients. Therefore, FGPs do need monitoring. The question is how often and how. At this stage, we would recommend that Xrays be repeated once a year to compare films with those of the previous year and that endoscopy be repeated for detailed examinations if any change is observed.
HPs need to be endoscopically examined once a year because they have malignant potential as
